(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Recruiting

Back to Indolent Systemic Mastocytosis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(63 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

David Geffen School of Medicine at UCLA, Los Angeles, California

Stanford Cancer Institute, Palo Alto, California

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus, Aurora, Colorado

Winship Cancer Institute, Emory University, Atlanta, Georgia

Brigham and Women's Hospital, Boston, Massachusetts

Michigan Medicine University of Michigan, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

Roswell Park Cancer Institute, Buffalo, New York

Columbia University Medical Center, New York, New York

Duke Asthma, Allergy and Airway Center, Durham, North Carolina

University of Cincinnati Medical Center, Cincinnati, Ohio

The University of Texas, MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah

Argentina

Consultorios Medicos Dr. Doreski - Fundacion Respirar, Buenos Aires

Australia

Princess Alexandra Hospital, Woolloongabba, Queensland

The Alfred Hospital, Melbourne, Victoria

Austria

Kepler Universitatsklinikum, Med Campus III. Clinic of Internal Medicine 3 - Hematology and Oncology, Linz

Belgium

Unitversitair Ziekenhuis Antwerpen, Edegem, Antwerpen

CHU Tivoli, La Louvière

Czechia

Fakultní nemocnice Královské Vinohrady, Hematologická klinika 3. LF UK v Praze a FNKV, Prague

France

CHU Amiens-Picardie, Amiens

CHU de Caen, Caen

CHU Grenoble, Grenoble

CHU de Limoges, Limoges

CHU de Nantes, Nantes

Hôpital de la Pitié Salpétrière, Paris

Hôpital Necker - Départementd 'HématologieA dultes, Paris

CHU de Poitiers, Poitiers

CHU Toulouse - Hopital Larrey, Toulouse

Germany

Universitätsklinikum RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation, Aachen

Charité - Universitätsmedizin Berlin Institute of Allergology, Berlin

University Clinic Erlangen, Erlangen

University Clinic Hamburg Eppendorf, Hamburg

Universitätsmedizin Mannheim III. Medizinische Klinik Universität Heidelberg Medizinische Fakultät Mannheim, Mannheim

LMU Klinikum, Munich

Greece

University General Hospital - General Hospital of West Attica, Chaïdári

General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki

Italy

UOC Ematologia, Milan, Lombardy

SOD Ematologia (Ambulatori)- AOUC Azienda Ospedaliero Universitaria Careggi, Florence, Tuscany

Unita Operativa di Ematologia AOU Policlinico S. Orsola-Malpighi, Bologna

AOU Policlinico G.Rodolico - San Marco, Catania

S.C. Ematologia Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia

S.S.D. Immunologia Clinica e Allergologia Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona, Salerno

Unità Operativa di Allergologia Azienda Ospedaliera Universitaria Integrata di Verona, Verona

Netherlands

ErasmusMC, Rotterdam, South Holland

University Medical Center Groningen, Groningen

Norway

Oslo University Hospital, Oslo

Poland

Uniwersyteckie Centrum Kliniczne Klinika Alergologii, Gdansk

Portugal

Centro Hospitalar de Lisboa Central, E.P.E. - Hospital de Santo Antonio dos Capuchos, Lisbon

CHUPorto, EPE - Hospital de Santo António, Porto

Centro Hospitalar Universitario Sao Joao, E.P.E., Porto

Spain

Hospital Universitario Vall d'Hebron, Barcelona

Hospital Universitario Ramon y Cajal, Madrid

Hospital Virgen del Valle - Instituto de Estudios de Mastocitosis de Castilla-La Mancha, Toledo

Sweden

Uppsala University Hospital, Uppsala

Switzerland

University Hospital Basel, Basel

Luzerner Kantonsspital, Lucerne

United Kingdom

University Hospital of Wales, Cardiff, Wales

University Hospital of Wales, Cardiff

Guy's and St Thomas's NHS Foundation Trust, London

Cancer and Haematology Centre, Oxford

University Hospital Plymouth NHS Trust, Plymouth

Trial locations(63 sites)

Interested in joining?